Curanex Pharmaceuticals Inc (CURX)

Curanex Pharmaceuticals Inc is a development-stage pharmaceutical company that discovers and develops botanical drugs for inflammatory diseases. The company, formerly known as Fordman Pharma, is headquartered in Jericho, New York.

Its lead product candidate, Phyto-N, is a botanical drug derived from plant extracts and is being developed for ulcerative colitis, with additional potential indications including atopic dermatitis and other inflammatory and metabolic conditions. Botanical drugs are complex plant-based mixtures that follow a distinct U.S. regulatory pathway. Curanex's work focuses on preclinical and clinical development of these candidates toward regulatory approval. Its common stock trades on Nasdaq under the ticker CURX.